From medical literature I have added several hundred drugs and their likely impact on the microbiome. A common problem with CFS patients is that they are only aware of some trademark name and not the standard scientific name.

I have started (it’s a long process) adding the common or trademark names to various drugs — for example Antivirals:

Now becomes

This process will likely take a few weeks to complete.

Antivirals and CFS

I have posted about this in the past ,”Valganciclovir antiviral and CFS[2016]” and  “Valacyclovir, EBV and CFS [2016]”.

I decided to look at the microbiome shifts seen with the valacyclovir hydrochloride  antiviral,  And was quite surprise to see a high number of bacteria taxonomy are reduced — which may account for the success reported in the above post “All patients were treated subsequently with valacyclovir, with 93% having a positive response” [2014]. The other antiviral, Valcyte or Valganciclovir, is not in my sources.

So, the question must be asked — was it’s antiviral nature OR microbiome modification nature that causes the reported improvement?